GEMER DS 3 MG TAB

1. All Details: Specifications
Dosage Form: Uncoated bilayer tablets (specifically formulated with a prolonged-release layer).
Storage Conditions: Store at room temperature, protected from light and moisture.
Batch Number (B.No.): GTF3936A
Manufacturing Date (Mfg.Dt.): 12/2024
Expiry Date (Exp.Dt.): 11/2026
Manufacturing License Number: M.L.: 374/DR/Mfg/2013
Maximum Retail Price (M.R.P.): Rs. 166.50 per 10 Tablets (Inclusive of all taxes).
Internal Material Identifier: 5221886
2. General
Brand: Gemer® DS 3
Generic Name: Metformin Hydrochloride Prolonged-Release and Glimepiride Tablets IP
Quantity: 10 Tablets per strip (indicated by “per 10 Tablets”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the statutory red caution warning boxes for Schedule G and Schedule H).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: 23 months (from December 2024 to November 2026).
Food Preference / FSSAI: Not Applicable. This product is a medical prescription drug for managing chronic health conditions, not a food product or dietary supplement. It falls strictly under the purview of national drug control authorities instead of the FSSAI, and it does not display vegetarian or non-vegetarian food preference icons.
3. Product Details: Ingredients
Each uncoated bilayer tablet contains:
Metformin Hydrochloride IP (as prolonged release): 1000 mg
Glimepiride IP: 3 mg
Excipients: q.s. (Quantity Sufficient)
Colour: Ferrosoferric Oxide USP-NF
4. Directions: How to Use
Administration Guide: Tablet should be swallowed whole and not to be chewed or crushed.
Dosage: As directed by the Physician.
Statutory Warning Labels:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision.
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: Gemer DS 3 is a double strength (“DS”) fixed-dose combination oral anti-diabetic medication. It combines an insulin-sensitizing biguanide (Metformin Hydrochloride in a prolonged-release format to ensure steady, continuous drug delivery) with a stronger 3 mg dose of an insulin-secreting sulfonylurea (Glimepiride). It is prescribed under strict medical oversight to help regulate blood sugar levels in patients with Type 2 diabetes mellitus.
Visual Presentation: The packaging features a distinctive light pink metallic blister backing with silver indentations, highlighted maroon branding panels, standard red cautionary restriction grids, and a bar code along the bottom edge.
6. Manufacturer Information
Manufactured in India by: sun pharma laboratories ltd.
Factory Address: Vill: Kokjhar, Mirza Palashbari Road, P.O.: Palashbari, Dist: Kamrup, Assam-781128.
7. Marketed By
Marketed By: Sun Pharmaceutical Industries Ltd.